Cargando…
Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in developing countries, presenting a major threat to the public health. The currently recommended long term treatment regimen with multiple antibiotics is associated with poor patient compliance, which in turn,...
Autores principales: | Ahmed, Sultan, Raqib, Rubhana, Guðmundsson, Guðmundur Hrafn, Bergman, Peter, Agerberth, Birgitta, Rekha, Rokeya Sultana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168302/ https://www.ncbi.nlm.nih.gov/pubmed/31936156 http://dx.doi.org/10.3390/antibiotics9010021 |
Ejemplares similares
-
Host Directed Therapy Against Infection by Boosting Innate Immunity
por: Bergman, Peter, et al.
Publicado: (2020) -
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy
por: Rekha, Rokeya Sultana, et al.
Publicado: (2018) -
Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011) -
Oral intake of phenylbutyrate with or without vitamin D(3) upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis
por: Mily, Akhirunnesa, et al.
Publicado: (2013) -
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
por: Mily, Akhirunnesa, et al.
Publicado: (2015)